Business Description
Arvinas Inc
NAICS : 325412
SIC : 2834
ISIN : US04335A1051
Description
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 230.84 | |||||
| Equity-to-Asset | 0.43 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.02 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -0.04 | |||||
| Beneish M-Score | -2.57 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 23.6 | |||||
| 3-Year EBITDA Growth Rate | -32.4 | |||||
| 3-Year EPS without NRI Growth Rate | -35.6 | |||||
| 3-Year FCF Growth Rate | -54.6 | |||||
| 3-Year Book Growth Rate | 21.7 | |||||
| Future 3-5Y Total Revenue Growth Rate | 29.76 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 16.39 | |||||
| 9-Day RSI | 27.17 | |||||
| 14-Day RSI | 34.91 | |||||
| 6-1 Month Momentum % | -8.54 | |||||
| 12-1 Month Momentum % | -39.27 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.44 | |||||
| Quick Ratio | 3.44 | |||||
| Cash Ratio | 3.38 | |||||
| Days Sales Outstanding | 1.96 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -11.4 | |||||
| Shareholder Yield % | 0.05 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -182.5 | |||||
| Net Margin % | -182.69 | |||||
| ROE % | -52.55 | |||||
| ROA % | -23.73 | |||||
| ROIC % | -129.03 | |||||
| ROC (Joel Greenblatt) % | -1660.89 | |||||
| ROCE % | -30.32 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 7.43 | |||||
| PB Ratio | 2.62 | |||||
| Price-to-Tangible-Book | 2.62 | |||||
| EV-to-EBIT | -0.65 | |||||
| EV-to-Forward-EBIT | -0.44 | |||||
| EV-to-EBITDA | -0.66 | |||||
| EV-to-Forward-EBITDA | -0.44 | |||||
| EV-to-Revenue | 1.18 | |||||
| EV-to-Forward-Revenue | 1.49 | |||||
| EV-to-FCF | -0.86 | |||||
| Price-to-Projected-FCF | 4.57 | |||||
| Price-to-Net-Current-Asset-Value | 2.78 | |||||
| Price-to-Net-Cash | 2.9 | |||||
| Earnings Yield (Greenblatt) % | -153.85 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ARVN
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Arvinas Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 162.9 | ||
| EPS (TTM) ($) | -5.59 | ||
| Beta | 1.97 | ||
| Volatility % | 40.7 | ||
| 14-Day RSI | 34.91 | ||
| 14-Day ATR ($) | 1.172732 | ||
| 20-Day SMA ($) | 26.3005 | ||
| 12-1 Month Momentum % | -39.27 | ||
| 52-Week Range ($) | 21.21 - 57.96 | ||
| Shares Outstanding (Mil) | 53.49 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Arvinas Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Arvinas Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Arvinas Inc Frequently Asked Questions
What is Arvinas Inc(ARVN)'s stock price today?
The current price of ARVN is $22.72. The 52 week high of ARVN is $57.96 and 52 week low is $21.21.
When is next earnings date of Arvinas Inc(ARVN)?
The next earnings date of Arvinas Inc(ARVN) is 2023-11-09 Est..
Does Arvinas Inc(ARVN) pay dividends? If so, how much?
Arvinas Inc(ARVN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers